6 days ago
- Business
- AU Financial Review
Sanofi's $2.5b deal to buy biotech with rights to Aussie vaccine invention
French pharmaceutical giant Sanofi is spending up to $US1.6 billion ($2.5 billion) to acquire a biotech with exclusive rights to a unique vaccine technology developed by University of Queensland scientists.
Sanofi is buying Vicebio, a London-based group, which is developing vaccines for two respiratory viruses using the molecular clamp technology invented by University of Queensland's professors Paul Young, Daniel Watterson and Keith Chappell.
